Hwail, succeeded in production of oseltamivir.

Published: 2005-12-08 06:57:00

Updated: 2005-12-08 06:57:00

A growing number of domestic pharmaceutical companies have succeeded in the production of oseltamivir, a main ingredient of Tamiflu, an anti-bird flu drug, including Hwail pharmaceutical Inc.

Hwail announced on Nov. 5 that the company had produced a bulk of oseltamivir phosphate after the succ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK